Abstract:
본발명은키레놀(kirenol) 또는이를함유하는시게스벡키아오리엔탈리스(Siegesbeckia orientalis L.) 추출물을유효성분으로포함하는비만예방, 개선또는치료용조성물에관한것이다. 본발명에따른키레놀(kirenol), 또는이를함유하는시게스벡키아오리엔탈리스추출물또는이의분획물은지방세포내에서지방세포분화에관여하는주요전사인자(PPARγ, C/EBPα, 및 SREBP-1c)의발현을감소시킴에따라, 비만에우수한효과가있다. 또한, 본발명은천연물이므로부작용없이안전하게사용될수 있어, 의약품또는식품으로사용될수 있다.
Abstract:
The present invention relates to a use of fucosterol, more specifically an anti-obesity composition comprising fucosterol. The fucosterol improves the lipogenesis control and heating activity for providing an excellent effect in anti-obesity. [Reference numerals] (AA) Fucosterol (쨉M)
Abstract:
The present invention relates to a pharmaceutical composition containing Kaempferia parviflora Wall. extract or flavone-based compound for muscular diseases treatment and, more specifically, a pharmaceutical composition containing the Kaempferia parviflora Wall. extract or flavone-based compound which is dissociated therefrom and presented by the chemical formula 4, as an active ingredient, for muscular diseases treatment and a food composition for improving muscular functions and exercise performance ability. The Kaempferia parviflora Wall. extract and flavone-based compound dissociated therefrom are effective in manufacturing the pharmaceutical composition for muscular diseases treatment or the food composition for improving muscular functions since the components decrease protein catabolism of muscles and increase muscle cell differentiation and anabolism. [Reference numerals] (AA) 5,7-dimethoxyflavone (쨉M)
Abstract:
PURPOSE: A composition containing macelignan, nutmeg extract, or salt thereof for preventing and treating allergic diseases is provided to relieve excessive immune response. CONSTITUTION: A pharmaceutical composition for preventing and treating allergic diseases contains macelignan or pharmaceutically acceptable salt thereof as an active ingredient. A food compoisiton for preventing and relieving allergic diseases contains macelignan or salt thereof as an active ingredient. A cosmetic composition for preventing and treating allergic diseases contains macelignan or salt thereof as an active ingredient. A pharmaceutical composition for preventing and treating allergic diseases contains nutmeg extract as an active ingredient.
Abstract:
A Panduratin A isolated from the extract of Kaempferia pandurata or its derivative is provided to inhibit growth of bacteria including acne-causing bacteria in the skin without side effects, so that it is useful for treatment of acnes effectively. An antibacterial composition comprises a Panduratin A compound isolated from the extract of Kaempferia pandurata, represented by the formula(1) or the formula(2), or its derivative, and inhibits growth of Propionibacterium acnes, Staphylococcus epidermis, Micrococcus luteus, Staphylococcus aureus, Staphylococcus warneri, Staphylococcus haemolyticus, Staphylococcus xylosus, Staphylococcus hominis and Staphylococcus saprophyticus, wherein the extract of Kaempferia pandurata is prepared by extracting Kaempferia pandurata with water or a C1-C6 organic solvent selected from alcohol, acetone, ether, benzene, chloroform, ethyl acetate, methylene chloride, hexane, cyclohexane and petroleum ether.
persica (L.) BATSCH)의 과실, 즉 도자 ( Persicae fructus )의 구성 중 도인 (amygdalin)을 제외한 과피 및 과육 추출물을 유효성분으로 함유하는 조성물에 관한 것으로, 구체적으로 본 발명의 도자 추출물은 시험관 내 ( in vitro ) 실험에서 우수한 티로시나제 저해활성을 나타내며 생체 내 ( in vivo ) 실험에서 멜라닌 합성 저해 활성을 나타내는 바 피부 미백용 화장료 조성물로 유용하게 이용될 수 있다. 도자, 미백, 티로시나제, 멜라닌, 화장료 조성물
Abstract:
A cosmetic composition with whitening activity is provided to have excellent tyrosinase inhibition activity and excellent melanogenesis inhibition activity by comprising an extract of Persicae fructus. The cosmetic composition comprises 0.001-90 wt.% of an extract of Persicae fructus which is prepared from pericarp and flesh of the Persicae fructus except amygdalin by using at least one solvent selected from the group consisting of water, C1-4 alcohol, propylene glycol, ethyl acetate, butylene glycol, ether, and chloroform.